Cytosolic phospholipase A2: a member of the signalling pathway of a new G protein α subunit in Sporothrix schenckii by Valentín-Berríos, Shirley et al.
BioMed  Central
Page 1 of 16
(page number not for citation purposes)
BMC Microbiology
Open Access Research article
Cytosolic phospholipase A2: a member of the signalling pathway of 
a new G protein α subunit in Sporothrix schenckii
Shirley Valentín-Berríos1, Waleska González-Velázquez2, Lizaida Pérez-
Sánchez2, Ricardo González-Méndez3 and Nuri Rodríguez-del Valle*2
Address: 1Department of Microbiology, San Juan Bautista School of Medicine, Box 4968, Caguas, PR 00726-4968, USA, 2Department of 
Microbiology and Medical Zoology, Medical Sciences Campus, University of Puerto Rico, PO Box 365067, San Juan, PR 00936-5067, USA and 
3Department of Radiological Sciences, Medical Sciences Campus, University of Puerto Rico, PO Box 365067, San Juan, PR 00936-5067, USA
Email: Shirley Valentín-Berríos - svalentin@sanjuanbautista.edu; Waleska González-Velázquez - waleska.gonzalez@upr.edu; Lizaida Pérez-
Sánchez - lizaida.perez@upr.edu; Ricardo González-Méndez - ricardo.gonzalez7@upr.edu; Nuri Rodríguez-del Valle* - nuri.rodriguez@upr.edu
* Corresponding author    
Abstract
Background:  Sporothrix schenckii is a pathogenic dimorphic fungus, the etiological agent of sporotrichosis, a
lymphocutaneous disease that can remain localized or can disseminate, involving joints, lungs, and the central nervous
system. Pathogenic fungi use signal transduction pathways to rapidly adapt to changing environmental conditions and S.
schenckii is no exception. S. schenckii yeast cells, either proliferate (yeast cell cycle) or engage in a developmental program
that includes proliferation accompanied by morphogenesis (yeast to mycelium transition) depending on the
environmental conditions. The principal intracellular receptors of environmental signals are the heterotrimeric G
proteins, suggesting their involvement in fungal dimorphism and pathogenicity. Identifying these G proteins in fungi and
their involvement in protein-protein interactions will help determine their role in signal transduction pathways.
Results: In this work we describe a new G protein α subunit gene in S. schenckii, ssg-2. The cDNA sequence of ssg-2
revealed a predicted open reading frame of 1,065 nucleotides encoding a 355 amino acids protein with a molecular weight
of 40.9 kDa. When used as bait in a yeast two-hybrid assay, a cytoplasmic phospholipase A2 catalytic subunit was identified
as interacting with SSG-2. The sspla2 gene, revealed an open reading frame of 2538 bp and encoded an 846 amino acid
protein with a calculated molecular weight of 92.62 kDa. The principal features that characterize cPLA2 were identified
in this enzyme such as a phospholipase catalytic domain and the characteristic invariable arginine and serine residues. A
role for SSPLA2 in the control of dimorphism in S. schenckii is suggested by observing the effects of inhibitors of the
enzyme on the yeast cell cycle and the yeast to mycelium transition in this fungus. Phospholipase A2 inhibitors such as
AACOCF3 (an analogue of archidonic acid) and isotetrandrine (an inhibitor of G protein PLA2 interactions) were found
to inhibit budding by yeasts induced to re-enter the yeast cell cycle and to stimulate the yeast to mycelium transition
showing that this enzyme is necessary for the yeast cell cycle.
Conclusion: A new G protein α subunit gene was characterized in S. schenckii and protein-protein interactions studies
revealed this G protein alpha subunit interacts with a cPLA2 homologue. The PLA2 homologue reported here is the first
phospholipase identified in S. schenckii and the first time a PLA2 homologue is identified as interacting with a G protein α
subunit in a pathogenic dimorphic fungus, establishing a relationship between these G proteins and the pathogenic
potential of fungi. This cPLA2 homologue is known to play a role in signal transduction and fungal pathogenesis. Using
cPLA2 inhibitors, this enzyme was found to affect dimorphism in S. schenckii and was found to be necessary for the
development of the yeast or pathogenic form of the fungus.
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Background
Sporothrix schenckii is a dimorphic fungus that produces
lymphocutaneous lesions in humans and animals. It is
the etiologic agent of sporotrichosis, a subcutaneous lym-
phatic mycosis with a worldwide distribution [1]. In its
saprophytic form it develops hyaline, regularly septated
hyphae and pyriform conidia which can be found single
or in groups in a characteristic daisy-like arrangement. The
yeast or parasitic form shows ovoid cells with single or
multiple budding.
In S. schenckii, dimorphism is both a proliferative and
morphogenetic process. We have reported that in
response to different environmental stimuli, S. schenckii
unbudded synchronized yeast cells, either proliferate
(yeast cell cycle) or engage in a developmental program
that includes proliferation accompanied by morphogene-
sis (yeast to mycelium transition). Dimorphism in S.
schenckii, depends on transmembrane signalling pathways
that respond to cell density [2,3], external pH [2,3], cyclic
nucleotides [4] and extracellular calcium concentration
[5].
Dimorphism is an adaptation response to changing envi-
ronmental conditions. The morphology displayed by
dimorphic fungi is probably the result of the stimulation
of membrane receptors by extracellular ligands. Heterot-
rimeric (αβγ) guanine nucleotide binding proteins have
been associated with membrane receptors and with mor-
phogenetic transition signalling in many eukaryotes, and
play a crucial role in fungal morphogenesis as well [6].
They constitute a family of GTP hydrolases involved in
signal transduction pathways. These proteins are coupled
to membrane receptors (GPCR) that recognize different
extracellular signals. The α subunits of the heterotrimeric
G proteins bind GTP. The interaction of a ligand with the
GPRC initiates the exchange of bound GDP for GTP in the
Gα subunit resulting in the dissociation of the heterot-
rimer into α-GTP and βγ subunits. The dissociated α-GTP
subunit and the βγ dimer, relay signals to different targets
resulting in changes in cytoplasmic ionic composition or
in second messenger levels (e.g., cAMP) that ultimately
lead to a cellular response [7-10].
Genes encoding proteins that are similar to the Gα class of
the heterotrimeric G proteins have been described in fila-
mentous fungi such as Aspergillus nidulans [11] and Neu-
rospora crassa [12-14], as well as in fungal plant pathogens
like Cryphonectria parasitica [15,16], Ustilago maydis [17]
and Magnaporthe grisea [18], among others. In S. schenckii,
a 41 kDa Gα subunit homologous to the Gαi subunit and
sensitive to inhibition by pertussis toxin was described
previously by us [19]. This was the first Gαi subunit
described in a pathogenic dimorphic fungus.
In higher eukaryotes, members of the Gα class are known
to regulate adenylate cyclase [20], cGMP phosphodieste-
rase [21], phosphoinositide-3-kinase [22], calcium and
potassium channels [22-24], and the activity of phosphol-
ipases [9,25-28]. In fungi, Gα subunits have been shown
to regulate adenylate cyclase, morphogenesis and patho-
genicity [6,14,29,30]. Most of the studies related to deter-
mining the role of the heterotrimeric G protein subunits
in fungi involved the observation of the morphological
effects produced in the fungus when these genes are
deleted [6,12,14,18]. Nevertheless, the full scope of the
processes that Gα subunits regulate in fungi is still not
known and interactions between these subunits and cellu-
lar proteins have seldom been reported in pathogenic
fungi.
A large number of G protein coupled receptors have been
observed to induce activation of phospholipase A2  in
higher eukaryotic systems [31]. The PLA2 superfamily can
be classified according to cellular location or biological
properties [32]. The phospholipase A superfamily
includes the calcium dependent-secretory PLA2 (sPLA2),
the calcium independent-intracellular PLA2 (iPLA2) and
the cytosolic PLA2 (cPLA2). They differ in terms of calcium
requirements, substrate specificity, molecular weight and
lipid modification. The sPLA2 is usually a 13 to 15 kDa
protein while the cPLA2 is a 85 kDa protein in human
macrophages. The cPLA2 possesses characteristics that sug-
gest that it is associated to receptor-activated signal trans-
duction cascades [33]. This PLA2 is known to translocate
to the membrane in response to an increase in intracellu-
lar calcium concentration [34]. Cytosolic PLA2 hydrolyses
the sn-2 position of phospholipids, resulting in the release
of lysophospholipids and free fatty acids. The most com-
monly released fatty acid is arachidonic acid, which in
turn is converted to eicosanoids that regulate multiple
processes including calcium channels, mitogenic signals
and most important, the inflammatory response of mac-
rophages [31,32,35,36].
The present study was undertaken to identify the presence
of and characterize additional Gα subunits in S. schenckii,
to identify any important interacting partners of the new
Gα subunit, and finally to determine the involvement if
any of the interacting protein, in this case cPLA2, in the
control of dimorphism in this fungus. Here we give details
of the identification and sequencing of the ssg-2  gene,
including gene organization, the presence and position of
introns, derived amino acid sequence and conserved
polypeptide-encoded domains. Using SSG-2 as bait, we
identified a cPLA2 homologue interacting with this G pro-
tein α subunit. We give the genomic sequence of this gene
and the complete derived amino acid sequence. We also
report the effects on the yeast to mycelium transition andBMC Microbiology 2009, 9:100 http://www.biomedcentral.com/1471-2180/9/100
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the yeast cell cycle of phopholipase effectors in S.
schenckii.
This work constitutes the first report of the presence of
multiple G protein α subunits in S. schenckii, the presence
of a cPLA2 homologue interacting with this G protein α
subunit, and the involvement of cPLA2 in the control of
dimorphism in S. schenckii. In addition to being a very
important determinant of pathogenicity in fungi and
other organisms, cPLA2 is shown to have a direct effect in
the control of dimorphism in this fungus. This informa-
tion will ultimately help us construct the signal transduc-
tion pathway leading from the G proteins onward and the
role of G proteins and its interacting partners in fungal
pathogenesis.
Results
Identification of the ssg-2 gene
Most fungal Gα subunit genes vary only slightly in size
within the region encoding the GESGKST and KWIHCF
motifs where primers for PCR are usually made because of
the conserved nature of these regions. In the region com-
prised between these primers size variations are usually
due to the presence of introns of slightly different sizes.
Two PCR products were obtained when using fungal DNA
as template and the GESGKST/KWIHCF primer pair one
belonging to ssg-1 and the other to ssg-2 of approximately
620 and 645 bp, respectively. The ssg-2 PCR product (645
bp) established the presence of a new gene encoding
another Gα subunit in S. schenckii. Figure 1A shows the
sequencing strategy used for the identification of this new
G protein α subunit gene. Once the coding sequence was
completed, it was confirmed using yeast cDNA as tem-
plate and the MGACMS/KDSGIL primer pair. A 1,065 bp
ORF was obtained, containing the coding region of the
ssg-2 cDNA as shown in Figure 1B. Using the same primer
pair and genomic DNA as template a 1,333 bp PCR prod-
uct was obtained. Sequencing of this PCR product con-
firmed the sequences obtained previously and showed the
presence and position of 4 introns. These introns had the
consensus GT/AG junction splice site and interrupted the
respective codons after the second nucleotide. The first
intron interrupted the codon for G42 and consisted of 82
bp, the second intron interrupted the codon for Y157 and
consisted of 60 bp, the third intron interrupted the codon
for H200 and consisted of 60 bp, the fourth intron starts
interrupted the codon H323 and consisted of 67 bp. With
the exception of the regions where introns were present in
the genomic sequence of the ssg-2  gene, the cDNA
sequence and genomic sequence were identical. The over-
lapping of these two sequences confirmed the presence of
the introns in the genomic sequence. The cDNA and
genomic sequence of ssg-2 have GenBank accession num-
bers AF454862 and AY078408, respectively.
Bioinformatic characterization of SSG-2
The derived amino acid sequence (GenBank accession
number AAL57853) revealed a Gα subunit of 355 amino
acids as shown in Figure 1B. The calculated molecular
weight of the ssg-2 gene product was 40.90 kDa. Blocks
analysis of the amino acid sequence of SSG-2 revealed a
G-protein alpha subunit signature from amino acids 37 to
276 with an E value of 5.2e-67 and a fungal G-protein
alpha subunit signature from amino acids 61 to 341 with
an E value of 3.3e-28 [37]. SSG-2 has the motifs encoding
the GTPase domain [38] with the corresponding consen-
sus sequences involved in GTP binding shaded in gray in
Figure 1B. The phosphate binding loop which includes
the sequence GXGXXGKS is found in SSG-2 as GSGES-
GKS. The magnesium binding residues with the consen-
sus sequence DXXG is present as DVGG in SSG-2, while
the guanine ring binding sites are those with the consen-
sus sequence NKXD is present as NKVD. The TXAT con-
sensus sequence is present as TQAT in SSG-2. Another
region involved in phosphate binding includes the con-
sensus sequence RXXT that in SSG-2 is present as RTKT. In
addition to these conserved domains, the protein derived
from the ssg-2 cDNA sequence has the N-terminal glycine
that is myristoylated in Gα subtypes and is needed for
membrane association. The 5 residues that identify the
adenylate cyclase interaction site according to BLAST anal-
ysis [39] are in red in Figure 1, these include I187, K212,
I215, H216, and E 219. The putative receptor binding site
includes amino acids L318 to R334 and is shown in blue
letters in Figure 1[39].
The derived amino acid sequence alignment of SSG-2 to
that of the several fungal homologues is shown in Figure
2. This figure shows more than 85% identity to MAGA of
M. grisea [18], CPG-2 of C. parasitica [16] and GNA-3 of
N. crassa [14]. Table 1 summarizes the percent identity of
SSG-2 to some members of the fungal Gα homologues
and SSG-1.
Yeast two-hybrid screening
Two independent yeast two-hybrid screenings, using dif-
ferent S. schenckii yeast cells cDNA libraries were done
with the complete coding sequence of SSG-2 as bait. In
both screenings, 3 blue colonies growing in quadruple
drop out (QDO) medium (SD/-Ade/-His/-Leu/-Trp/X-α-
gal) were identified as containing the same PLA2 homo-
logue insert. The expression of the Ade+, His+ phenotypes
and α galactosidase activity are considered by the manu-
facturer as corroborative of true interactions. The inserts
from all three colonies were found to contain the carboxy-
terminal residues of a protein homologous to PLA2's from
A. nidulans. Our results indicated that the last 162 amino
acids of the S. schenckii cPLA2 homologue interacted with
SSG-2.BMC Microbiology 2009, 9:100 http://www.biomedcentral.com/1471-2180/9/100
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cDNA and derived amino acid sequences of the S. schenckii ssg-2 gene Figure 1
cDNA and derived amino acid sequences of the S. schenckii ssg-2 gene. Figure 1A shows the sequencing strategy used 
for ssg-2. The size and location in the gene of the various fragments obtained from PCR and RACE are shown. The black boxes 
indicate the size and relative position of the introns. Figure 1B shows the cDNA and derived amino acid sequence of the ssg-2 
gene. Non-coding regions are given in lower case letters, coding regions and amino acids are given in upper case letters. The 
sequences that make up the GTPase domain are shaded in gray, the five residues that identify the adenylate cyclase interaction 
site are given in red and the putative receptor binding site is shown in blue.BMC Microbiology 2009, 9:100 http://www.biomedcentral.com/1471-2180/9/100
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Co-immunoprecipitation (Co-IP)
The SSG-2-SSPLA2 interaction was corroborated by co-
immunoprecipitation. Figure 3 shows the confirmation of
the interaction observed in the yeast two-hybrid assay
between SSG-2 and SSPLA2 by co-immunoprecipitation
and Western blot analysis. Lane 1 shows the band
obtained using anti-cMyc antibody that recognizes SSG-2.
This band is of the expected size (62 kDa) considering that
SSG-2 was expressed fused to the GAL-4 binding domain.
The two high molecular weight bands present belong to
the anti-cMyc antibodies used for precipitation. Lane 2
shows the results obtained in the Western blot when the
Amino acid sequence alignments of SSG-2 with other Gα subunit homologues Figure 2
Amino acid sequence alignments of SSG-2 with other Gα subunit homologues. The predicted amino acid sequence 
of S. schenckii SSG-2 and SSG-1, C. parasitica CPG2, N. crassa GNA3, R. necatrix WGA1, E. nidulans GANB, and M grisea MAGA 
were aligned as described in Methods. In the alignment, black shading with white letters indicates 100% identity, gray shading 
with white letters indicates 75–99% identity, gray shading with black letters indicates 50–74% identity.
Table 1: Comparison of G protein alpha subunit homologues to SSG-2 of S. schenckii
UniProt AC Name Length Organism Name Overlap %iden E-value Score
Q8TF91 SSG2 355 Sporothrix schenckii 355 100 0 729
O13314 MAGA 356 Magnaporthe grisea 355 88 0 642
Q00581 CPG2 355 Cryphonectria parasitica 355 87 0 640
Q9HFW7 GNA3 356 Neurospora crassa 356 85 e-177 623
Q9HFA3 WGA1 356 Rosellinia necatrix 355 84 e-175 619
Q9UVK8 GANB 356 Emericella nidulans 356 77 e-160 567
O74259 SSG1 353 Sporothrix schenckii 353 50 2e-93 346
SSG-1 is included as reference. Analysis was carried out using iProtClass database and the BLAST algorithm. Overlap refers to the number of 
residues used to determine SSG-2% identity when doing pairwise comparisons.BMC Microbiology 2009, 9:100 http://www.biomedcentral.com/1471-2180/9/100
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primary anti-cMyc antibody was not added (negative con-
trol). Lane 3 shows the band obtained using anti-HA anti-
body that recognizes the original SSPLA2  fragment
isolated from the yeast two-hybrid clone. This band is of
the expected size (35.9 kDa) considering that only the last
162 amino acids of the protein were present and that this
fragment was fused to the GAL-4 activation domain. Lane
4 shows the results obtained in the Western blot when the
primary anti-HA antibody was not added (negative con-
trol).
Sequencing of the sspla2 gene
Figure 4A shows the sequencing strategy used for the sspla2
gene. The DNA sequence of sspla2 gene was completed
using genome walking and PCR. Figure 4B shows the
genomic and derived amino acid sequence of the sspla2
homologue. The genomic sequence has 2648 bp with an
open reading frame of 2538 bp encoding an 846 amino
acid protein with a predicted molecular weight of 92.6
kDa. The GenBank numbers for the genomic and derived
amino acid sequence are FJ357242.1 and ACJ04517.1,
respectively.
Bioinformatic characterization of SSPLA2
The PANTHER Classification System identified this pro-
tein as a member of the cytosolic phospholipase A2 family
(PTHR10728) (residues 132–827) with an extremely sig-
nificant E value of 6.4 e-97 [40]. BLAST analysis of the
derived amino acid sequence of the S. schenckii SSPLA2,
showed a phospholipase domain extending from amino
acids 177 to 750 [39]. Pfam analysis shows similar results,
and in this domain the PLA2 signature GXSG [G, S] (Pfam:
Family PLA2_B PF 01735) is present as GVSGS in the
active site (highlighted green in Figure 4B) [41,42]. The
amino acids needed for catalytic activity R235, S263 and
D553 are given in red in this same figure [43]. S263 is
essential for the formation of arachidonyl serine needed
for the transfer of the arachidonyl group to glycerol or to
water. The amino acids D511 to L523, D583 to G595 and
D738 to A750 (highlighted in yellow) comprise putative
EF hand domains of the protein (76% identity, probabil-
ity, 3.33e-06). In Figure 4B a putative calmodulin binding
domain was identified from amino acids Q806 to L823
using the Calmodulin Target Database [44] and high-
lighted in gray. A serine protease, subtilase family, aspartic
acid active site motif was identified using Scan Prosite
with an E value of 5.283e-07 from amino acids 549 to 559
and is shaded in blue green in Figure 4B[45]. This motif is
characteristic of both yeast and fungal cPLA2 homologues
[43].
Figure 5 shows the multiple sequence alignment of the
derived amino acid sequence of S. schenckii PLA2 homo-
logue to that of other PLA homologues or hypothetical
proteins from N. crassa, A. nidulans, M. grisea, Chaetomium
globosum, Podospora anserina and Gibberella zeae. This figure
shows that the important domains are very similar,
although variations occur in the N terminal and C termi-
nal regions. The alignment shown includes only the cata-
lytic domain, the complete alignment is given as
additional material (Additional file 1).
Effects of PLA2 effectors on the yeast to mycelium 
transition and the yeast cell cycle
S. schenckii is not a genetically manageable organism,
therefore, effectors of PLA2 were tested for their effects on
the yeast to mycelium transition and the yeast cell cycle.
Arachidonic acid is the primary product of cPLA2 activity
on phospholipids, while AACOCF3 and isotetrandrine are
inhibitors of PLA2 activity. AACOCF3 is a known compet-
itive inhibitor of PLA2 [46]. It is an analogue of arachi-
donic acid and presumably binds directly to the active site
of the enzyme. It is a potent and selective inhibitor of
cytosolic phospholipase A [46]. Isotetrandrine on the
Western Blots results from SSG-2/SSPLA2 co-immunoprecip- itation Figure 3
Western Blots results from SSG-2/SSPLA2 co-immu-
noprecipitation. Whole cell free extracts of S. cerevisiae 
cells containing PGBKT7 and PGADT7 plasmids with the 
complete SSG-2 coding region fused to the GAL4 activation 
domain and cMyc, and the initial SSPLA2 coding fragment 
identified in the yeast two-hybrid assay fused to the GAL4 
DNA binding domain and HA, respectively, were co-immu-
noprecipitated as described in Methods. The co-precipitated 
proteins were separated using 10% SDS polyacrylamide elec-
trophoresis and transferred to nitrocellulose. The nitrocellu-
lose strips were probed with anti-cMyc antibodies (Lane 1) 
and anti HA antibodies (Lane 3). Lanes 2 and 4 are negative 
controls where no primary antibody was added. The antigen-
antibody reactions were detected using the Immun-Star™ 
AP chemiluminescent protein detection system. Pre-stained 
molecular weight markers were included in outside lanes of 
the gel and also transferred to nitrocellulose, the position of 
the molecular weight markers is indicated in the figure.BMC Microbiology 2009, 9:100 http://www.biomedcentral.com/1471-2180/9/100
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Genomic and derived amino acid sequences of the S. schenckii sspla2 gene Figure 4
Genomic and derived amino acid sequences of the S. schenckii sspla2 gene. Figure 4A shows the sequencing strategy 
used for sequencing the sspla2 gene. The size and location in the gene of the various fragments obtained from PCR and RACE 
are shown. Figure 4B shows the genomic and derived amino acid sequence of the sspla2 gene. Non-coding regions are given in 
lower case letters, coding regions and amino acids are given in upper case letters. The invariant amino acids required for phos-
pholipase activity are shown in red. The potential EF hands are shaded in yellow and the putative calmodulin binding domain is 
shaded in gray. The cPLA2 signature motif is shaded in green and the serine proteases, subtilase family, aspartic acid active site 
motif is shaded in blue green.BMC Microbiology 2009, 9:100 http://www.biomedcentral.com/1471-2180/9/100
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other hand is an alkaloid that has been reported to inter-
fere with G protein activation of PLA2 [47]. Figure 6 shows
the percentage of yeast cells forming germ tubes in the
presence and absence of arachidonic acid, AACOCF3 and
isotetrandrine. This figure shows that these latter com-
pounds significantly stimulated the yeast to mycelium
transition at 6 and 9 h of incubation when the control
cells are in the process of DNA synthesis and germ tube
emergence [2]. The percent stimulation was approxi-
mately 68% and 33% at 6 h and 9 h of incubation in the
presence of both AACOCF3 and isotetrandrine. In the
presence of arachidonic acid a slight (25%) non-signifi-
cant inhibition was observed at 6 h of incubation. The
degree of stimulation caused by the addition of AACOCF3
and isotetrandrine was similar even though the mecha-
nism of action of these compounds is completely differ-
ent.
Figure 7 shows the percentage of budding in yeast cells
induced to re-enter the cell cycle in the presence and
absence of arachidonic acid, AACOCF3  and isotetran-
drine. The percent inhibition observed in the presence of
both AACOCF3  and isotetrandrine was approximately
60% and 40% at 9 h of incubation, respectively. Arachi-
donic acid on the other hand significantly stimulated
budding at 6 h of incubation (percent stimulation was
Amino acid sequence alignments of SSPLA2 with other PLA2 homologues Figure 5
Amino acid sequence alignments of SSPLA2 with other PLA2 homologues. The S. schenckii SSPLA2 was aligned to 
other PLA2 fungal homologues as described in Methods. The fungal PLA2 used for the alignment were: E. nidulans (PLA2), M. gri-
sea (hypothetical protein), N. crassa (PLA2), C. globosum (hypothetical protein), P. anserina (hypothetical protein) and G. zeae 
(PLA2). The alignment was done using MCOFFEE and visualized using the program GeneDoc. Only the catalytic core of these 
proteins is shown in this alignment, from amino acids 192 to 611 (in reference to the multiple alignment position). The black 
shading with white letters indicates 100% identity, gray shading with white letters indicates 75–99% identity, gray shading with 
black letters indicates 50–74% identity.BMC Microbiology 2009, 9:100 http://www.biomedcentral.com/1471-2180/9/100
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50%). At this time interval, control cells are initiating
DNA synthesis [3].
Discussion
The heterotrimeric G protein family ranks among the
most important protein families identified as intracellular
recipients of external signalling. The present study was
conducted in order to describe new Gα subunit encoding
genes in S. schenckii, identify any important protein inter-
acting with this G alpha subunit and determine the effects
on dimorphism in S. schenckii of the protein or proteins
identified.
The results presented here, together with our previous
report [19] corroborate the existence of more than one
heterotrimeric G protein α subunit gene in S. schenckii.
Unpublished results indicate that this protein is one of at
least 3 Gα subunits present in S. schenckii. In this sense, S.
schenckii is behaving more like the filamentous fungi and
plant pathogens such as N. crassa [14], C. parasitica [48]
and M. grisea [18], where genes that encode 3 different Gα
subunits similar to the Gα class of animals rather than to
the GPA group present in yeasts and plants. Computa-
tional sequence and phylogenetic analysis of the Gα sub-
units in filamentous fungi shows the existence of 3
distinct subfamilies of G protein alpha subunits [19].
According to the classification offered by Li and collabo-
rators, SSG-2 belongs to Group III of the fungal G protein
alpha subunits [49]. The Group III considered by them to
be Gαs analogues because they positively influence cAMP
levels although they have more sequence similarity to Gαi
[49].
The nucleotide and amino acid sequence analysis of this
new G protein α subunit gene are different from the pre-
viously identified ssg-1 gene. The nucleotide conservation
of the coding region of ssg-2 is less than 50% when com-
pared to that of the previously reported ssg-1 gene, con-
firming that ssg-1 and ssg-2 are two different genes (data
not shown). The derived amino acid sequence of ssg-2 is
50% identical to that of SSG-1, but they have differences
in the motifs that are characteristic of the G protein alpha
subunits, the most important difference being that SSG-2
lacks the cysteine residue in domain 5 that characterizes
the pertussis binding domain of SSG-1 (TCADT). For this
reason, SSG-2 belongs to the Gα class but cannot be
strictly considered a Gαi, even though it is 46% identical
Effects of SSPLA2 effectors on the yeast to mycelium transi- tion Figure 6
Effects of SSPLA2 effectors on the yeast to mycelium 
transition. Yeast cells grown, harvested, synchronized and 
selected by filtration as described in Methods were induced 
to form germ tubes in a basal medium with glucose at pH 4.0 
and incubated at 25°C in the presence and absence of arachi-
donic acid (40 μM), AACOCF3 (100 μM; Nonadeca-
4,7,10,13-tetraenyl-trifluoro-methyl ketone)) and isotetran-
drine (50 μM; 6,6',7,12-tetra methoxy-2,2'-dimethyl-ber-
baman). All values are given as the average percentage ± one 
SD of at least three independent experiments. The Student's 
t test was used to determine the statistical significance of the 
data at a 95% confidence level. Values that differ significantly 
from those of the control at 95% confidence level are 
marked with an asterisk.
Effects of SSPLA2 effectors on the yeast budding cycle Figure 7
Effects of SSPLA2 effectors on the yeast budding 
cycle. Yeast cells grown, harvested, synchronized and 
selected by filtration as described in Methods were induced 
to re-enter the budding cycle in a basal medium with glucose 
at pH 7.2 and incubated at 25°C in the presence and absence 
of arachidonic acid (40 μM), AACOCF3 (100 μM; Nonadeca-
4,7,10,13-tetraenyl-trifluoro-methyl ketone) and isotetran-
drine (50 μM; 6,6',7,12-tetra methoxy-2,2'-dimethyl-ber-
baman). All values are given as the average percentage ± one 
SD of at least three independent experiments. The Student's 
t test was used to determine the statistical significance of the 
data at a 95% confidence level. Values that differ significantly 
from those of the control at 95% confidence level are 
marked with an asterisk.BMC Microbiology 2009, 9:100 http://www.biomedcentral.com/1471-2180/9/100
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to mammalian Gαi class members. This shows the high
degree of conservation in Gα subunits even among phyl-
ogenetically distant organisms.
The work done in order to identify the role of Gα subunits
in the filamentous fungi has been mainly concerned with
the phenotypes observed when these genes are knocked-
out (as reviewed by [6]). In this paper a different approach
was used. We wanted to identify important protein-pro-
tein interactions between SSG-2 and the complex signal-
ling system that regulates the flow of information from
the environment through the heterotrimeric G proteins
into the cell in S. schenckii. Using the yeast two-hybrid
technique we identified a cPLA2 homologue as interacting
with SSG-2 in two independent experiments, using two
different cDNA libraries. This SSG-2-PLA2 interaction was
also confirmed by co-immunoprecipitation. Up to date,
protein-protein interactions of these Gα subunits have
not been reported in the pathogenic fungi, and the exact
proteins with which these Gα subunits interact have not
been identified. This is the first report of a cytosolic PLA2
homologue interacting with a G protein α subunit in a
pathogenic dimorphic fungus, suggesting a functional
relationship between these two important proteins. Other
proteins interact with SSG-2 (unpublished results), but
the SSG-2-PLA2 interaction is very important as it connects
this G protein α subunit with both pathogenicity and
lipid signal transduction in fungi [50].
This PLA2 homologue belongs to the Group IV PLA2 fam-
ily that has been highly conserved throughout evolution.
BLAST searches of the amino acid sequence of SSPLA2
against the Homo sapiens database shows that it is phylo-
genetically related to the human Group IVA PLA2 family.
This same analysis using the fungal databases revealed
that SSPLA2 is more closely related to the phospholipases
of the filamentous fungi than to PLAB of yeasts. The sim-
ilarity to both human and fungal phospholipases is found
primarily in the catalytic domain with a great deal of var-
iation contained in the first and last 200 amino acids. In
the catalytic domain we find an important difference
between SSPLA2 and the human homologues. The former
has one continuous catalytic domain, rather than the
more typical cPLA2 structure where two homologous cata-
lytic domains are present, interspaced with unique
sequences [43].
SSPLA2  lacks the C2 motif found in cPLA2  of higher
eukaryotes. This domain is involved in the translocation
of the enzyme to the membrane in response to an increase
in intracellular calcium concentration [34]. Nevertheless,
SSPLA2 has 3 putative EF hand motifs suggesting that it
could also be calcium modulated. EF hand motifs are also
present in the PLA2 homologues of M. grisea, G. zeae, N.
crassa and A. nidulans in different areas of these proteins.
It is interesting to note that A. nidulans PLA2 has been
reported to be responsive to calcium even though it also
lacks a C2 domain [51].
Also contributing to the possible modulation by calcium
of this protein is the presence of a putative calmodulin
binding domain [44]. As in the case of the EF hand-
motifs, analysis of the PLA2 homologues of M. grisea, N.
crassa, G. zeae and in A. nidulans show the presence of pos-
sible calmodulin binding domains in different areas of
the proteins [44]. In S. schenckii the putative calmodulin
binding domain is at the C terminal end of the protein,
while in M. grisea, N. crassa and G. zeae it is within the first
150 to 250 amino acids.
In addition to the identification of PLA2 as interacting
with SSG-2, we inquired as to the effects of PLA2 in S.
schenckii  dimorphism. As mentioned previously, PLA2
hydrolyses the sn-2 position of phospholipids, resulting
in the release of lysophospholipids and free fatty acids.
The most commonly released fatty acid is arachidonic
acid. We tested the effects of exogenously added arachi-
donic acid on the kinetics of germ tube formation or the
yeast cell cycle in S. schenckii. Our results show that exog-
enously added arachidonic acid had no significant effect
on the kinetics of the yeast to mycelium transition, but a
significant stimulation (50%) in the percentage of bud-
ding in cells induced to re-enter the yeast cell cycle was
observed at 6 h of incubation in the presence of this com-
pound. The observed stimulation of the yeast cell cycle by
arachidonic acid is consistent with the inhibitory effects
on this same cycle observed in the presence of AACOCF3
and isotetrandrine in S. schenckii, inhibitors of PLA2.
These inhibitors have different mechanisms of action as
stated previously. AACOCF3 is a competitive inhibitor of
PLA2 [46] and an analogue of arachidonic acid, while iso-
tetrandrine interferes with G protein activation of PLA2
[47]. Both AACOCF3 and isotetrandrine increased signif-
icantly the percentage of cells with germ tubes at 6 and 9
h after inoculation and decreased budding in cells
induced to re-enter the yeast cycle. The AACOCF3 results
are consistent with our hypothesis that PLA2 activity is
needed for the yeast cell cycle in S. schenckii, specifically at
the start of DNA synthesis [3]. Furthermore, the isotetran-
dine results support the hypothesis that the interaction of
SSG-2 with PLA2 is required for these processes to occur.
It is of interest to note that we recently reported similar
results in the presence of calmodulin inhibitor W7 and
inhibitors of calcium-calmodulin kinase in S. schenckii
[52]. Inhibiting calmodulin or calmodulin-dependent
kinase also inhibited the re-entry of yeast cells into the cell
cycle. We can speculate that by inhibiting the calmodulin
dependent kinase we are also inhibiting the migration of
cPLA2 to the membrane and/or its activation.BMC Microbiology 2009, 9:100 http://www.biomedcentral.com/1471-2180/9/100
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We cannot fully ascertain the functional consequences of
the observed interaction between PLA2 and SSG-2 at this
time. Future work will help us clarify this relationship.
Nevertheless, two important processes that have a bearing
in cell cycle progression have been identified as subjected
to cPLA2 activity in other systems: 1) the production of
biologically active molecules and 2) membrane remode-
ling [53].
There is very little information regarding the effects of the
primary metabolites released from the action of PLA2 (ara-
chidonic acid and lysophospholipids) in fungi, Arachi-
donic acid was reported to stimulate adenylate cyclase
[54] in S. cerevisiae. If this is also true for S. schenckii, addi-
tion of arachidonic acid to the medium would be
expected to stimulate the yeast cell cycle and this was what
we observed. We had previously reported that dibutyryl
derivatives of cAMP inhibit the yeast to mycelium transi-
tion in S. schenckii [4].
On the other hand, membrane remodeling is also an
important function of enzymes such as phospholipases.
This process is needed for cell cycle progression and fun-
gal morphogenesis [53]. It has been reported in other sys-
tems that in order for the cell cycle to occur there must be
a careful balance between membrane phospholipid syn-
thesis and degradation. PLA2 has an important role in the
maintenance of this balance [35,55]. The lipid composi-
tion of the membrane is also essential for the correct
receptor-protein interactions and plays an important role
in signal transduction. G proteins are usually in molar
excess when compared to the GPRC's and a large number
of inactive GDP-bound heterotrimeric G protein mole-
cules must be available in receptor-rich domains associ-
ated to membrane lipids [56].
G proteins can also affect PLA2 activity by a number of dif-
ferent mechanisms such as: increasing the intracellular
calcium concentration, transcriptional regulation and
stimulation of phosphorylation through different protein
kinases such as protein kinase C and MAP kinases (for a
review see [57]).
The studies presented here constitute the first evidence of
the interaction of G protein subunits of fungi with a phos-
pholipase. These results establish for the first time a rela-
tionship between G proteins and the pathogenic
determinants of fungi. The identification of such an
important protein as partners of a G protein alpha subunit
in fungi suggests a mechanism by which these G proteins
can control pathogenicity in fungi. The existence of the
interaction reported here may offer an explanation as to
why fungi with decreased G protein alpha subunits such
as C. parasitica, hypovirus infection [15] and M. grisea
with disrupted Gα subunit gene, magB, exhibit reduced
levels of virulence [18]. This information is essential if we
are to understand the disease producing process of fungi.
It will also help elucidate the signal transduction pathway
leading from the G protein onward and will give us a bet-
ter insight into signal transduction in pathogenesis and
dimorphism in S. schenckii.
Conclusion
We have shown the presence of a new G protein α subunit
in S. schenckii, SSG-2. The cDNA sequence of the ssg-2
gene encoded a 355 amino acid Gα subunit of 40.90 kDa
containing the 5 consensus domains present in all Gα
subunits. The genomic sequence has four introns, whose
positions are conserved in the other fungal homologues
of this gene.
Yeast two-hybrid analysis using the complete amino acid
sequence of SSG-2 identified a PLA2 homologue as an
interacting partner of this G protein subunit. This 846
amino acid protein was encoded by an intronless gene.
The 92.62 kDa protein encoded by this gene contained all
the domains and amino acid residues that characterize
cytosolic phospholipase A2.
PLA2 and other phospholipases in fungi have very diverse
roles not only as virulence factors but also in membrane
homeostasis and signal transduction. Inhibitor studies
showed that this PLA2 homologue and its interaction with
SSG-2 were necessary for the re-entry of S. schenckii yeast
cells into the budding cycle suggesting a role for this
important virulence factor in the control of dimorphism
in this fungus and for the expression of the yeast form. The
effects of PLA2 on the yeast cell cycle could be viewed as
resulting from the generation of lipid messenger mole-
cules or from membrane remodelling that affects the G1-
>S transition and G protein activity.
The relationship reported here between these two pro-
teins, SSG-2 and SSPLA2, constitutes the first report of the
interaction of a fungal phospholipase and a G protein
subunit and the possible involvement of G protein in fun-
gal virulence and morphogenesis.
Methods
Strains and culture conditions
S. schenckii (ATCC 58251) was used for all experiments.
The yeast form of this fungus was obtained as described
[2]. S. cerevisiae strains AH109 and Y187 were supplied
with the MATCHMAKER Two-Hybrid System 3 (Clontech
Laboratories Inc., Palo Alto, CA).
Nucleic acids isolation
DNA and RNA were obtained from S. schenckii yeast cells
as described previously using the methods of Sherman
[58], and Chomczynski & Sacchi [59], respectively. PolyBMC Microbiology 2009, 9:100 http://www.biomedcentral.com/1471-2180/9/100
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A+ RNA was obtained from total RNA using the mRNA
Purification Kit from Amersham Biosciences (Piscataway,
NJ, USA).
Sequencing the ssg-2 gene
Polymerase chain Reaction and Rapid amplification of cDNA ends 
(RACE)
S. schenckii DNA (100 ng) was used as template for
polymerase chain reaction (PCR) with primers (100–200
ng) targeted to conserved motifs in Gα subunits. The
primers used were: GESGKST (fw) 5' ggtgc(c/t)ggtga(a/
g)tc(a/c)gg(a/t)aa(a/g)tc 3'; KWIHCF (rev) 5' aagcag
tgaatccacttc 3'; TQATDT (rev) 5'gtatcggtagcttgggtc 3';
MGACMS (fw) 5' atggg ggcttgcatgagt 3' and KDSGIL (rev)
5' taggataccggaatctttg 3'. The Ready-to-Go™ PCR Beads
(Amersham Biosciences) were used for PCR using the
amplification parameters described previously [52].
PCR products were isolated and cloned using the TOPO
TA Cloning System (Invitrogen Corp., Carlsbad, CA, USA)
[19]. Plasmid preparations were obtained using the Fast
Plasmid TM Mini technology from Eppendorf (Brink-
mann Instruments, Inc. Westbury, NY, USA).
The 5' and 3' ends of the S. schenckii Gα subunit gene were
obtained using SMART RACE (BD Biosciences, Clontech,
Palo Alto CA, USA). All RACE reactions were carried out
as described previously [19]. Primers for RACE were
designed based on the sequence obtained previously.
Nested primers were designed to improve the original
amplification reactions. Bands from the 5' and 3' nested
PCR, respectively, were excised from the gel, cloned and
sequenced [19]. The following primers were used for 3'
RACE: GSP2A (fw) 5' cttgaggaaagcagtcagaaccgaatgatg 3'
and GSP2C (fw) 5' gtgaatcgggcacacctcaacttatatcct 3'. The
following primers were used for 5' RACE: GSP1E (rev) 5'
catcattcggttctgactgctttcctcaag 3'; GSP1D (rev) 5' aaagtcg-
cagtacgcacggatctcatcgct 3' and SSG-2 5 'UTR primer-1
(rev) 5' tagcagtagaatcttgcattctcgccgt 3' and SSG-2 5' UTR
primer-2 (rev) 5' tcctcttcttctgctccacctcctcact 3'.
The complete coding sequence of the ssg-2  gene from
cDNA and genomic DNA were obtained using reverse
transcriptase polymerase chain reaction (RTPCR) and end
to end PCR, respectively. The cDNA obtained using the
RETROscript™ First Strand Synthesis kit (Ambion, Applied
Biosystems, Foster City, CA, USA) was used as template.
The following primers were used: MGACMS (fw)/KDSGIL
(rev) primer pair. The sequence of these primers were the
following: 5' atgggggcttgcatgagt 3' and 5' aggataccg-
gaatctttg 3', respectively. For the genomic sequence PCR,
DNA was used as template and the primers used were the
same as those used for RTPCR. The PCR products contain-
ing the entire coding sequence, from both the cDNA and
genomic templates were cloned and sequenced.
Sequencing the sspla2 gene
Polymerase chain Reaction and Genome Walker
The 5' sequence of the PLA2 homologue was obtained
using a combination of PCR and Genome Walker (Clon-
tech Laboratories Inc., Palo Alto, CA, USA). Genomic
DNA was used as template for PCR. For genome walking
a Pvu II library of S. schenckii genomic DNA done as
described by the manufacturer was used as template for
the primary specific PCR reactions using the gene specific
primers (GSP) and AP1 primer. The primary PCR reac-
tions were used as template for nested PCR using nested
gene specific primers (NGSP) and AP2 primer. The prim-
ers used were: YARRFA (NGSP, rev) 5' ccgagagacgat-
gcaaagcgacgggcgta 3'; SLLVFS (GSP and NGSP, rev) 5'
agagaagacgaggagact 3'; GSLSDEIWRE (rev) 5'
ctcgcgccaaatctcgtcggacagggatcc 3'; VHPEVQ (GSP, rev) 5'
gaactggacttcggggtg 3'; LAKYLDLPA (NGSP, rev) 5' ggcag-
ggaggtcgaggtacttggcgag 3'; (fw) 5' ctcgccaagtacctcgacctccct-
gccg 3'; DDVPVIA (rev) 5' aacgcaatcacgggcacgtcgtcgg 3';
GVSGSGC (fw) 5' ggagtgagcggttcatgctgg 3'; LYFSSFT (rev)
5' taaacgacgaaaagtacag 3'; PVGVGWPPA (GSP, rev) 5'
cggccggcggccagcccacacccactgg 3'; PVGVG (fw) 5' ccagtgggt-
gtgggctg 3'; DDKIEQ (fw) 5' gacgacattgaacaggccaaagccgac
3'; DKIEQ (rev) 5' ttcaatcttgtcgtccgg 3'; ERHKRERL (rev) 5'
cagccgctccctcttgtgccgctcctc 3'; NOVGGR (NGSP, rev) 5'
ctccgacttaattaaaat 3'; 3' UTR primer (GSP, rev) 5' atgctgt-
gtcgccctccgac 3'. The AP1 and AP2 primers supplied by the
manufacturer. The touchdown and nested PCR parame-
ters used were those described previously [60].
DNA sequencing and analysis
All sequencing reactions for the ssg-2 gene were conducted
using the ABI PRISM™ 377 automated DNA sequencer
(Applied Biosystems) and the Thermo Sequenase II Dye
terminator Cycle Sequencing Premix Kit (Amersham Bio-
sciences) as described previously [19]. Sequencing of the
sspla2 gene products was done commercially using the
SeqWright sequencing service (Fisher Scientific, Houston,
TX, USA)
Bioinformatics Sequence Analysis
The theoretical molecular weights were calculated using
the on-line ExPASy tool http://www.expasy.ch/tools/. On-
line Prosite Scan (Proscan Search) search was used to
identify potential motifs present in SSG-2 and SSPLA2
http://npsa-pbil.ibcp.fr/cgi-bin/
npsa_automat.pl?page=npsa_prosite.html[45]. The pro-
tein classification was performed using the PANTHER
Gene and Protein Classification System http://www.pan
therdb.org[40] and on-line Blocks Analysis Server http://
blocks.fhcrc.org/blocks/blocks_search.html[37]. The cal-
modulin-binding domain was identified using the on line
Calmodulin Target Database http://calcium.uhnres.uto
ronto.ca/ctdb/ctdb/sequence.html[44]. On-line database
searches and comparisons for SSG-2 were performedBMC Microbiology 2009, 9:100 http://www.biomedcentral.com/1471-2180/9/100
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using the Integrated Protein Classification (iProClass)
database [61] and its BLAST algorithm implementation
with a cutoff of 10-7, a low complexity filter and the Blo-
sum 62 matrix. The iProClass/UniProt accession numbers
of the sequences used for the multiple sequence align-
ment of G protein subunits were: S. schenckii (SSG-2),
Q8TF91;  M. grisea (MAGA), O13314; C. parasitica
(CPG2), Q00581; N. crassa (GNA3) Q9HFW7; R. necatrix
(WGA1/RGA1), Q9HFA3; E. nidulans (GANB), Q9UVK8,
and S. schenckii (SSG-1), O74259.
On-line database searches and comparisons for SSPLA2
were performed with the BLAST algorithm http://
www.ncbi.nlm.nih.gov/BLAST/ with a cutoff of 10-7, a low
complexity filter and the BLOSUM 62 matrix [39]. The
Pfam analysis was done on-line using the using the Well-
come Trust Sanger Institute server http://
pfam.sanger.ac.uk/[42]. The GenBank accession numbers
for the multiple sequence alignment of phospholipases
were:  A. nidulans (PLA2), XP_663815;  S. schenckii
(SSPLA2), ACJ04517.1; M. grisea (hypothetical protein),
XP_363597;  N. crassa (PLA2), XP_962511;  C. globosum
(hypothetical protein) XP_001223932; P. anserina (hypo-
thetical protein) XP_001909265, and G. zeae (PLA2),
XP_382145.
Multiple sequence alignments were built using MCOFFEE
http://www.igs.cnrs-mrs.fr/Tcoffee/tcoffee_cgi/
index.cgi[62]. The alignments were visualized using the
program GeneDoc http://www.nrbsc.org/downloads/.
Yeast two-hybrid
MATCHMAKER Two-Hybrid System 3 was used for the
yeast two-hybrid assay (Clontech Laboratories Inc., Palo
Alto, CA) using all 3 different reporter genes for the con-
firmation for truly interacting proteins. For the construc-
tion of the bait plasmid, ssg-2 cDNA was obtained from
poly A+ RNA, transcribed and amplified by RT-PCR using
the Ready-to-Go TM Beads (Amersham Biosciences). The
RT-PCR product was amplified using primers containing
the gene sequence and an additional sequence containing
restriction enzyme sites, Xma I and BamH I at the 5' and
3' ends, respectively. The primers used were: Xma I-
MGACMS (fw) 5' ccccggggatgggggcttgcatgagt 3' and
DSGIL-BamH I (rev) 5' cgcggatccgcgctaggataccggaatctt 3'.
The ssg-2 gene PCR product was cloned in frame into the
linearized bait plasmid, pGBKT7 (Clontech Laboratories
Inc.) using Quick T4 DNA ligase kit (New England Biolabs
Inc., Ipswich, MA, USA) and amplified in E. coli by trans-
formation. Sequencing corroborated the sequence, correct
orientation, and frame of the inserted gene. The bait con-
taining plasmid was isolated using Fast Plasmid™ Mini
technology (Brinkmann Instruments, Inc.) and used to
transform competent S. cerevisiae yeast cells (Y187). Com-
petent S. cerevisiae yeast cells were transformed using the
YEASTMAKER™ Yeast Transformation System 2 from
Clontech (BD Biosciences, Clontech Laboratories Inc.).
Tests for autonomous gene activation and cell toxicity
were carried out also as described by the manufacturer.
Double stranded cDNA was synthesized from S. schenckii
yeast cells Poly A+ RNA using SMART™ Technology Kit
(Clontech Laboratories Inc.). The cDNA's were amplified
using Long Distance PCR and size selected using the BD
CHROMA-SPIN™+TE-400 columns (Clontech Laborato-
ries Inc.).
S. cerevisiae yeast cells AH109 were made competent using
the lithium-acetate (LiAc) method mentioned above and
transformed with SMART ds cDNA (20 μl) previously
amplified by LD-PCR and the linearized pGADT7-Rec
(Sma I-linearized plasmid). Transformants were selected
in SD/-Leu plates, harvested and used for mating with the
bait containing S. cerevisiae strain Y187. Mating of S. cere-
visiae yeast cells strains Y187 (Mat-α) and AH109 (Mat-a)
was done according to the manufacturer's instructions.
The expression of three reporter ADE2, HIS3 and MEL1
genes in the diploids was used as confirmation for true
interacting proteins. Diploids expressing interacting pro-
teins were selected in triple drop out medium (TDO), SD/
-Ade/-Leu/-Trp. Colonies growing in TDO medium were
tested for growth and α-galactosidase production in quad-
ruple drop out medium (QDO), SD/-Ade/-His/-Leu/-Trp/
X-α-gal. Re-plating of these positive colonies into QDO
medium was done at least 3 times to verify that they main-
tain the correct phenotype. Colony PCR was also done to
corroborate the presence of both plasmids in the diploid
cells using the T7/3'BD sequencing primer pair for the
pGBKT7/ssg-2 plasmid and the T7/3'AD primer pair for
the pGADT7-Rec library plasmid. The PCR products
obtained with the T7 Sequencing Primer/3'AD Sequenc-
ing Primer pair were cloned and sequenced as described
above.
Co-immunoprecipitation (Co-IP)
S. cerevisiae diploids obtained in the yeast two-hybrid
assay were grown in 125 ml flasks containing 25 ml of
QDO for 16 h, harvested by centrifugation and resus-
pended in 4 ml containing phosphate buffer saline (400
μl) with phosphatase inhibitor (400 μl), deacetylase
inhibitor (40 μl) (Active Motif North America, Carlsbad,
CA, USA) and protease inhibitors cocktail (40 μl) (EDTA-
free, Thermo Scientific, Pierce Biotechnology, Rockford,
IL, USA). The cells were frozen in a porcelain mortar in
liquid nitrogen, glass beads added and the cells broken as
described previously [63]. The cell extract was centrifuged
and the supernatant used for Co-IP using the Immunopre-
cipitation Starter Pack (GE Healthcare, Bio-Sciences AB,
Bjorkgatan, Sweden) as described by the manufacturer.
Briefly, 500 μl of the cell extract (1–2 ug of protein/ml)BMC Microbiology 2009, 9:100 http://www.biomedcentral.com/1471-2180/9/100
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were combined with 1–5 μl of the anti-cMyc antibody
(Clontech, Corp.) and incubated at 4°C for 4 h, followed
by the addition of protein G beads and incubated at 4°C
overnight in a rotary shaker. The suspension was centri-
fuged and the supernatant discarded, 500 μl of the wash
buffer added followed by re-centrifugation. This was
repeated 4 times. The pellet was resuspended in Laemmeli
buffer (20 μl) and heated for 5 min at 95°C, centrifuged
and the supernatant used for 10% SDS PAGE at 110 V/1
h. Pre-stained molecular weight standards were electro-
phoresed in outside lanes of the gel (BioRad Corporation,
Hercules, CA, USA).
Western Blots
Western blots were done as described by us previously
[63]. The electrophoretically separated proteins were
transferred to nitrocellulose membranes using the BioRad
Trans Blot SystemR for 1 h at 20 volts. After transferring,
the nitrocellulose strips were blocked with 3% gelatin in
TTBS (20 mM Tris, 500 mM NaCl, 0.05% Tween-20, pH
7.5) at room temperature for 30–60 min. The strips were
washed for 5–10 min with TTBS. The TTBS was removed
and the strips incubated overnight in the antibody solu-
tion containing 20 μg of antibody, anti-cMyc or anti-HA
(Clontech, Corp.) was added to each strip. Controls where
the primary antibody was not added were included. The
antigen-antibody reaction was detected using the Immun-
Star™ AP chemiluminescent protein detection system
from BioRad Corporation as described by the manufac-
turer.
Induction of the yeast to mycelium transition
The yeast form of the fungus was obtained from conidia
as described previously [2]. Briefly, yeast cell were grown
for 5 days from conidia in 125 ml flasks containing 50 ml
of medium M with aeration at 35°C. These cells were fil-
tered through sterile Whatman #1 filters (GE Healthcare
Life Sciences). This procedure increases the concentration
of undbudded singlets to approximately 90%. The cells
were collected by filtration using Millipore filters
GSWP04700 (0.2 μm) (Millipore Corp. Billerica, MA,
USA), washed using basal medium with glucose and used
for inoculation to give a final concentration of 105 cells/
ml. These cells were induced to form germ tubes in the
presence and absence of effectors of PLA2 activity in a
basal medium with glucose at pH 4.0 and 25°C. Parallel
cultures were inoculated with unbudded yeast cells and at
6 and 9 h after inoculation the content of a flask was fil-
tered for the determination of the percentage of cells with
germ tubes for each of the substances tested. These same
yeast cells were inoculated to give a final concentration of
107 cells/ml and induced to re-enter the yeast cell cycle as
described previously in the presence and absence of effec-
tors of PLA2 in a basal medium with glucose at pH 7.2 and
25°C with aeration. At 6 and 9 h after inoculation sam-
ples were taken and the percentage of budding cells was
recorded.
The following substances were tested for their effects on
the yeast to mycelium transition and the yeast cell cycle:
arachidonic acid (40 μM; AACOCF3 (100 μM; Nonadeca-
4,7,10,13-tetraenyl-trifluoro-methyl ketone) [46] and iso-
tetrandrine (50 μM; 6,6',7,12-tetra methoxy-2,2'-dime-
thyl-berbaman) [47]. These substances were obtained
from Calbiochem, EMD Biosciences Inc. (Darmstadt, Ger-
many). The results are expressed as the average percentage
of cells with germ tubes or buds at 6 and 9 h of incubation
± one standard deviation of at least three independent
determinations. The Student t test was used to determine
the statistical significance of the data. A 95% confidence
level was used to determine statistical significance.
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